Effect of abiotic factors on the diversity and abundance of aquatic macroinvertebrates in the East and West Branches of the Maple River, Michigan, USA

General EcologyStreams are home to a wide variety of aquatic organisms including fish and benthic macroinvertebrates. Variance in diversity and abundance of macroinvertebrates in stream ecosystems is influenced by water chemistry and substrate availability. Different substrates provide macroinvertebrates with varying habitats, protection, and resources. Four distinct sites on the East and West branches of the Maple River around Pellston, MI were sampled and studied to examine the combined effects of abiotic factors on macroinvertebrate diversity and abundance. At each site, three substrates (cobble, gravel, and sand) were studied. Rocky riverbed substrates (i.e. gravel and cobble) contained greater numbers and more diverse macro invertebrate families than sandy substrates. Stable isotope analysis of the water from each site showed a correlation between the abundance of individuals and groundwater concentration but did not show a correlation between diversity of families and groundwater concentration.https://deepblue.lib.umich.edu/bitstream/2027.42/140071/1/Freimark_Jameson_Jubera_Schneider-2017.PDFDescription of Freimark_Jameson_Jubera_Schneider-2017.PDF : Freimark, C., E. Jameson, K. Jubera, and B. Schneider_201

Ein livländisches Herz : Katharina I von Russland : geschichtlicher Roman

http://www.ester.ee/record=b4374851*es

First-in-man evaluation of 124I-PGN650: A PET tracer for detecting phosphatidylserine as a biomarker of the solid tumor microenvironment

Purpose: PGN650 is a F(ab′) 2 antibody fragment that targets phosphatidylserine (PS), a marker normally absent that becomes exposed on tumor cells and tumor vasculature in response to oxidative stress and increases in response to therapy. PGN650 was labeled with 124 I to create a positron emission tomography (PET) agent as an in vivo biomarker for tumor microenvironment and response to therapy. In this phase 0 study, we evaluated the pharmacokinetics, safety, radiation dosimetry, and tumor targeting of this tracer in a cohort of patients with cancer. Methods: Eleven patients with known solid tumors received approximately 140 MBq (3.8 mCi) 124 I-PGN650 intravenously and underwent positron emission tomography–computed tomography (PET/CT) approximately 1 hour, 3 hours, and either 24 hours or 48 hours later to establish tracer kinetics for the purpose of calculating radiation dosimetry (from integration of the organ time-activity curves and OLINDA/EXM using the adult male and female models). Results: Known tumor foci demonstrated mildly increased uptake, with the highest activity at the latest imaging time. There were no unexpected adverse events. The liver was the organ receiving the highest radiation dose (0.77 mGy/MBq); the effective dose was 0.41 mSv/MBq. Conclusion: Although 124 I-PGN650 is safe for human PET imaging, the tumor targeting with this agent in patients was less than previously observed in animal studies

Integrated pest management in historical collections of the 21st century

Many museum collections are at risk for pest infestation, but historical collections\ud in particular are susceptible to these degradations due to the prevalence of materials that\ud attract pests. In the past, collections have been treated with chemical methods, but more\ud recently, a new methodological approach, called Integrated Pest Management, or IPM,\ud has emerged in caring for collections. In this thesis, Integrated Pest Management, defined as an integrative method of pest control, is examined in museums caring for historical collections. A survey of museums in North America that care for historical collections was conducted, resulting in a response rate of roughly 20%. After a discussion, a set of conclusions and recommendations is offered. It is concluded that museums with historical collections have largely integrated IPM into their efforts and that IPM is a significant advance in collections stewardship over traditional methods

Reverse remodeling and the mechanism of mitral regurgitation improvement in patients with dilated cardiomyopathy

Background: Functional mitral regurgitation (MR) is a common finding in dilated cardiomyopathy. Left ventricular (LV) reverse remodeling with LV size reduction and improvement in LV function is a well recognized phenomenon. We aimed to evaluate the impact of LV remodeling on the mechanism leading to functional MR. Methods: Among 188 patients with non-ischemic dilated cardiomyopathy, 10 patients significantly improved their LV function, reduced LV size and MR severity during follow-up (RRMR). A comparison was made between their baseline and follow-up echocardiographic examinations and to a matched-control group of patients who did not improve (no RRMR). LV and left atrium (LA) dimensions and volumes, LV mass (LVM), LV ejection fraction (LVEF) (Simpsons), sphericity index (SI), mitral valve tenting area (TA) coaptation distance (CD), effective regurgitant orifice (ERO), and regurgitant volume were calculated. Multivariable analysis was performed in order to evaluate which echocardiographic parameters related to MR improvement in reverse remodeling. Results: LV and LA dimensions and volumes, LVM, SI, TA, CD, ERO and right ventricle, in the RRMR group significantly decreased at follow-up (p < 0.04 for all). When compared to no RRMR, despite a similar ERO (0.2 ± 0.05 vs. 0.2 ± 0.08, p = 0.13) and a larger regurgitant volume (38 ± 9 vs. 29 ± 8 mL, p = 0.05) and despite similar clinical characteristics and medical treatment we found significantly higher LVEF, smaller LV dimensions and volumes, smaller LVM and SI in the RRMR group (p < 0.05 for all). On multivariable analysis the SI was the sole predictor of RRMR (p = 0.04, OR = 0.76, CI 0.58–0.99). Conclusions: Reverse remodeling characterized by improvement in LV function, reduction in LV size and an associated reduction in MR severity is related to LV SI at baseline.

Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center

Aim: To assess outcomes among patients with Duchenne muscular dystrophy receiving deflazacort or prednisone in real-world practice. Methods: Clinical data for 435 boys with Duchenne muscular dystrophy from Cincinnati Children\u27s Hospital Medical Center were studied retrospectively using time-to-event and regression analyses. Results: Median ages at loss of ambulation were 15.6 and 13.5 years among deflazacort- and prednisone-initiated patients, respectively. Deflazacort was also associated with a lower risk of scoliosis and better ambulatory function, greater % lean body mass, shorter stature and lower weight, after adjusting for age and steroid duration. No differences were observed in whole body bone mineral density or left ventricular ejection fraction. Conclusion: This single center study adds to the real-world evidence associating deflazacort with improved clinical outcomes

Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier – Part A: Inoculation, cultivation, and cell harvest procedures

Human mesenchymal stem cells (hMSC) are a promising cell source for several applications of regenerative medicine. The used cells are either autologous or allogenic, whereas the latter enables, especially by using of stem cell lines, a production of cell therapeutic or tissue engineered implants in stock. Therefore, the usually small initial cell number has to be increased. For that purpose bioreactors are demanded, which offer the controlled expansion of the hMSC under GMP-conform conditions. In this study, divided in part A and B, a fixed bed bioreactor system based on non-porous borosilicate glass spheres for the expansion of hMSC, demonstrated with the model cell line hMSC-TERT, is introduced. The system offers a comfortable automation of the inoculation, cultivation, and harvesting procedures. Furthermore the bioreactor owns a simple design which benefits the manufacturing as disposable. Part A is focused on the inoculation, cultivation, and harvesting procedures. Cultivations were performed in lab scales up to a bed volume of 300 cm3. It could be shown that the fixed bed system, based on 2-mm borosilicate glass spheres, as well as the inoculation, cultivation, and harvesting procedures are suitable for the expansion of hMSC with high yield and vitality

The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion

AbstractObjectives. We sought to examine the hypothesis that rapid resolution of ST-segment elevation in acute myocardial infarction (AMI) patients with early peak creatine kinase (CK) after thrombolytic therapy differentiates among patients with early recanalization between those with and those without adequate tissue (myocardial) reperfusion.Background. Early recanalization of the epicardial infarct-related artery (IRA) during AMI does not ensure adequate reperfusion on the myocardial level. While early peak CK after thrombolysis results from early and abrupt restoration of the coronary flow to the infarcted area, rapid ST-segment resolution, which is another clinical marker of successful reperfusion, reflects changes of the myocardial tissue itself.Methods. We compared the clinical and the angiographic results of 162 AMI patients with early peak CK (≤12 h) after thrombolytic therapy with (group A) and without (group B) concomitant rapid resolution of ST-segment elevation.Results. Patients in groups A and B had similar patency rates of the IRA on angiography (anterior infarction: 93% vs. 93%; inferior infarction: 89% vs. 77%). Nevertheless, group A versus B patients had lower peak CK (anterior infarction: 1,083 ± 585 IU/ml vs. 1,950 ± 1,216, p < 0.01; and inferior infarction: 940 ± 750 IU/ml vs. 1,350 ± 820, p = 0.18) and better left ventricular ejection fraction (anterior infarction: 49 ± 8, vs. 44 ± 8, p < 0.01; inferior infarction: 56 ± 12 vs. 51 ± 10, p = 0.1). In a 2-year follow-up, group A as compared with group B patients had a lower rate of congestive heart failure (1% vs. 13%, p < 0.01) and mortality (2% vs. 13%, p < 0.01).Conclusions. Among patients in whom reperfusion appears to have taken place using an early peak CK as a marker, the coexistence of rapid resolution of ST-segment elevation further differentiates among patients with an opened culprit artery between the ones with and without adequate myocardial reperfusion

A label-free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen

In order to assess the biological function of proteins and their modifications for understanding signaling mechanisms within cells as well as specific biomarkers to disease, it is important that quantitative information be obtained under different experimental conditions. Stable isotope labeling is a powerful method for accurately determining changes in the levels of proteins and PTMs; however, isotope labeling experiments suffer from limited dynamic range resulting in signal change ratios of less than ,20:1 using most commercial mass spectrometers. Label-free approaches to relative quantification in proteomics such as spectral counting have gained popularity since no additional chemistries are needed. Here, we show a label-free method for relative quantification based on the TIC from peptide MS/MS spectra collected from data-dependent runs can be used effectively as a quantitative measure and expands the dynamic range over isotope labeling experiments allowing for abundance differences up to ,60:1 in a screen for proteins that bind to phosphotyrosine residues. Methods for acquiring quantitative proteomics data are continually developing with very accurate stable isotope labeling (SIL) and label-free approaches. SIL provides chemically equivalent but isotopically different internal standards for each peptide/protein for direct comparison of mass spectral signal intensities that represent relative abundance. Common SIL strategies include protein level labeling strategies such as stable isotope labeling of amino acids in cell culture (SILAC) [1], a global method whereby all translated proteins have isotope labels metabolically incorporated at selected amino acid residues, and isotope-coded affinity tags (ICAT) [2], a technique that labels cysteine residues at the protein level. Peptide level labeling strategies include multiplexed isobaric tags for relative and absolute quantification (iTRAQ